Cargando…
Expression in human prostate of drug- and carcinogen-metabolizing enzymes: association with prostate cancer risk.
The role of two common polymorphisms of enzymes involved in the metabolism of drugs and carcinogens was studied in relation to prostate cancer. The gene encoding one of these enzymes (NAT2) is located in an area where frequent allelic loss occurs in prostate cancer. Mutations at the genes CYP2D6 and...
Autores principales: | Agúndez, J. A., Martínez, C., Olivera, M., Gallardo, L., Ladero, J. M., Rosado, C., Prados, J., Rodriguez-Molina, J., Resel, L., Benítez, J. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063181/ https://www.ncbi.nlm.nih.gov/pubmed/9823980 |
Ejemplares similares
-
Tobacco smoking, polymorphisms in carcinogen metabolism enzyme genes, and risk of localized and advanced prostate cancer: results from the California Collaborative Prostate Cancer Study
por: Shahabi, Ahva, et al.
Publicado: (2014) -
Genetic Variants of Alcohol Metabolizing Enzymes and Alcohol-Related Liver Cirrhosis Risk
por: Ayuso, Pedro, et al.
Publicado: (2021) -
Effects of resveratrol on drug‐ and carcinogen‐metabolizing enzymes, implications for cancer prevention
por: Guthrie, Ariane R., et al.
Publicado: (2017) -
Co-carcinogenic effects of vitamin E in prostate
por: Vivarelli, Fabio, et al.
Publicado: (2019) -
Cytogenetic markers of susceptibility: influence of polymorphic carcinogen-metabolizing enzymes.
por: Norppa, H
Publicado: (1997)